Da An Gene Co Ltd of Sun Yat-Sen University (002030) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Da An Gene Co Ltd of Sun Yat-Sen University (002030) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥111.80 Million ≈ $16.36 Million USD) by net assets (CN¥7.99 Billion ≈ $1.17 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Da An Gene Co Ltd of Sun Yat-Sen Univers (002030) balance sheet quality index to measure how much of total assets are equity-financed.
Da An Gene Co Ltd of Sun Yat-Sen University - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Da An Gene Co Ltd of Sun Yat-Sen Univers's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Da An Gene Co Ltd of Sun Yat-Sen University Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Da An Gene Co Ltd of Sun Yat-Sen University ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MPC Container Ships ASA
OL:MPCC
|
0.080x |
|
Genusplus Group Ltd
AU:GNP
|
0.609x |
|
Generation Development Group Ltd
AU:GDG
|
0.037x |
|
MasterBrand Inc.
NYSE:MBC
|
0.065x |
|
Varroc Engineering Limited
NSE:VARROC
|
0.199x |
|
ChemoMetec A/S
CO:CHEMM
|
0.139x |
|
Zhejiang Huangma Technology Co Ltd
SHG:603181
|
0.043x |
|
Jingjin Environmental Protection Co Ltd
SHG:603279
|
0.050x |
Annual Cash Flow Conversion Efficiency for Da An Gene Co Ltd of Sun Yat-Sen University (2002–2025)
The table below shows the annual cash flow conversion efficiency of Da An Gene Co Ltd of Sun Yat-Sen University from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Da An Gene Co Ltd of Sun Yat-Sen Univers stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.36 Billion ≈ $1.08 Billion |
CN¥319.49 Million ≈ $46.75 Million |
0.043x | +17.62% |
| 2024-12-31 | CN¥8.14 Billion ≈ $1.19 Billion |
CN¥300.33 Million ≈ $43.95 Million |
0.037x | -60.07% |
| 2023-12-31 | CN¥9.16 Billion ≈ $1.34 Billion |
CN¥845.76 Million ≈ $123.76 Million |
0.092x | -74.18% |
| 2022-12-31 | CN¥11.62 Billion ≈ $1.70 Billion |
CN¥4.15 Billion ≈ $607.99 Million |
0.358x | -17.09% |
| 2021-12-31 | CN¥7.66 Billion ≈ $1.12 Billion |
CN¥3.30 Billion ≈ $483.56 Million |
0.431x | -22.54% |
| 2020-12-31 | CN¥4.51 Billion ≈ $660.64 Million |
CN¥2.51 Billion ≈ $367.95 Million |
0.557x | +1150.55% |
| 2019-12-31 | CN¥2.09 Billion ≈ $305.47 Million |
CN¥92.97 Million ≈ $13.60 Million |
0.045x | -75.02% |
| 2018-12-31 | CN¥2.20 Billion ≈ $322.01 Million |
CN¥392.38 Million ≈ $57.42 Million |
0.178x | +314.17% |
| 2017-12-31 | CN¥2.64 Billion ≈ $386.56 Million |
CN¥-219.93 Million ≈ $-32.18 Million |
-0.083x | +44.25% |
| 2016-12-31 | CN¥2.55 Billion ≈ $373.61 Million |
CN¥-381.28 Million ≈ $-55.79 Million |
-0.149x | -4908.78% |
| 2015-12-31 | CN¥1.94 Billion ≈ $283.84 Million |
CN¥-5.78 Million ≈ $-846.26K |
-0.003x | -106.75% |
| 2014-12-31 | CN¥914.64 Million ≈ $133.84 Million |
CN¥40.38 Million ≈ $5.91 Million |
0.044x | +24.06% |
| 2013-12-31 | CN¥758.10 Million ≈ $110.93 Million |
CN¥26.98 Million ≈ $3.95 Million |
0.036x | +560.85% |
| 2012-12-31 | CN¥626.21 Million ≈ $91.63 Million |
CN¥3.37 Million ≈ $493.43K |
0.005x | -95.38% |
| 2011-12-31 | CN¥554.12 Million ≈ $81.09 Million |
CN¥64.54 Million ≈ $9.44 Million |
0.116x | -28.88% |
| 2010-12-31 | CN¥482.34 Million ≈ $70.58 Million |
CN¥78.99 Million ≈ $11.56 Million |
0.164x | +29.14% |
| 2009-12-31 | CN¥428.60 Million ≈ $62.72 Million |
CN¥54.35 Million ≈ $7.95 Million |
0.127x | +68.67% |
| 2008-12-31 | CN¥385.31 Million ≈ $56.38 Million |
CN¥28.97 Million ≈ $4.24 Million |
0.075x | +164.42% |
| 2007-12-31 | CN¥309.15 Million ≈ $45.24 Million |
CN¥8.79 Million ≈ $1.29 Million |
0.028x | -73.47% |
| 2006-12-31 | CN¥280.69 Million ≈ $41.07 Million |
CN¥30.09 Million ≈ $4.40 Million |
0.107x | +3.99% |
| 2005-12-31 | CN¥269.70 Million ≈ $39.47 Million |
CN¥27.80 Million ≈ $4.07 Million |
0.103x | +70.61% |
| 2004-12-31 | CN¥256.72 Million ≈ $37.57 Million |
CN¥15.51 Million ≈ $2.27 Million |
0.060x | -75.73% |
| 2003-12-31 | CN¥92.08 Million ≈ $13.47 Million |
CN¥22.92 Million ≈ $3.35 Million |
0.249x | +40.25% |
| 2002-12-31 | CN¥69.03 Million ≈ $10.10 Million |
CN¥12.25 Million ≈ $1.79 Million |
0.177x | -- |
About Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coro… Read more